公开(公告)号：US11718879B2

公开(公告)日：2023-08-08

申请号：US16644812

申请日：2018-09-05

申请人： AMONETA DIAGNOSTICS ,  Hueseyin Firat ,  Saliha Moussaoui ,  Eric Schordan

发明人： Hueseyin Firat ,  Saliha Moussaoui ,  Eric Schordan

IPC分类号： C12Q1/6883

CPC分类号： C12Q1/6883 ,  C12Q2600/158 ,  C12Q2600/178

摘要： The present invention describes a method for the diagnosis of a cognitive disorder including but not limited to Alzheimer disease in a subject at risk of having or developing a cognitive disorder.

公开(公告)号：US20210269881A1

公开(公告)日：2021-09-02

申请号：US17274019

申请日：2019-09-05

申请人： AMONETA DIAGNOSTICS SAS

发明人： Saliha MOUSSAOUI ,  Hueseyin FIRAT ,  Eric SCHORDAN

IPC分类号： C12Q1/6883

摘要： The present invention describes a method for the therapeutic treatment and/or for the diagnosis of a brain disorder including but not limited to cognitive disorders such as mild cognitive impairment, Alzheimer disease, frontotemporal dementia, dementia with Lowy body in a subject at risk of having or developing a brain disorder such as cognitive disorder, using long non-coding RNA (IncRNA).

公开(公告)号：US20210071252A1

公开(公告)日：2021-03-11

申请号：US16644812

申请日：2018-09-05

申请人： Hueseyin FIRAT ,  Saliha MOUSSAOUI ,  Eric SCHORDAN ,  AMONETA DIAGNOSTICS

发明人： Hueseyin FIRAT ,  Saliha MOUSSAOUI ,  Eric SCHORDAN

IPC分类号： C12Q1/6883

摘要： The present invention describes a method for the diagnosis of a cognitive disorder including but not limited to Alzheimer disease in a subject at risk of having or developing a cognitive disorder.

公开(公告)号：US20190094246A1

公开(公告)日：2019-03-28

申请号：US16083440

申请日：2017-03-07

申请人： AMONETA DIAGNOSTICS SAS ,  JPT PEPTIDE TECHNOLOGIES GMBH ,  CNRS - Centre National de la Recherche Scientifiqu ,  Université de Strasbourg

发明人： Saliha MOUSSAOUI ,  Dirk WILDEMANN ,  Holger WENSCHUH ,  Karsten SCHNATBAUM ,  Gilles ULRICH ,  Jean DE BARRY ,  Corinne MBEBI-LIEGEOIS ,  Hueseyin FIRAT

IPC分类号： G01N33/68 ,  C07K14/47 ,  C07F5/02

摘要： The present invention relates to a biomarker, and/or methods including a non-invasive in vitro method using this biomarker, for diagnosing or monitoring the development or the progression of Alzheimer's disease (AD) or a disease or disorder associated with β-amyloid peptide (Aβ) deposition or tau hyperphosphorylation or a disease or disorder characterized by a proteinopathy implicating abnormalities in protein kinase C (PKC).

公开(公告)号：US09377472B2

公开(公告)日：2016-06-28

申请号：US13874052

申请日：2013-04-30

申请人： Amoneta Diagnostics ,  Centre National de la Recherche Scientifique

发明人： Corinne Mbebi-Liegeois ,  Jean De Barry ,  Francois Sellal

IPC分类号： G01N33/68 ,  C07K14/47 ,  A01K67/027

CPC分类号： G01N33/6896 ,  A01K67/0275 ,  A01K2217/072 ,  A01K2227/105 ,  A01K2267/0312 ,  C07K14/4711 ,  G01N2333/4709 ,  G01N2500/10 ,  G01N2800/2821 ,  G01N2800/50

摘要： A biomarker for Alzheimer's disease (AD) comprising a complex of an Aβ amyloid peptide and a cell or a cellular membrane. Non-invasive methods for diagnosing Alzheimer's disease or monitoring its development or progression using this biomarker.

摘要翻译： 阿尔茨海默病（AD）的生物标志物，其包含A和Bgr的复合物; 淀粉样肽和细胞或细胞膜。 使用该生物标志物诊断阿尔茨海默氏病或​​监测其发展或进展的非侵入性方法。